top of page

Eszter Nagy, MD, PhD

Eszter is a serial entrepreneur with 25 years of biotech experience in discovery, translational research, pre-clinical and early clinical product development.

She founded CEBINA, the Central European Biotech Incubator and Accelerator in 2018 where she acts as CEO and CSO. She co-founded 5 biotech companies: MAG-LAB GmbH (2021), Algonist Biotechnologies GmbH (2020), Calyxha Biotechnologies GmbH (2019), Eveliqure Biotechnologies GmbH (2012), a clinical-stage company where she is President and Chair of the Board; and Arsanis, Inc. (2010) (ASNS, NASDAQ, now X4 Biopharmaceuticals, XFOR), where she served as CSO and managing director of the wholly-owned subsidiary, Arsanis Biosciences GmbH (Vienna, Austria) till 2018.

She has raised > €100Mio investment and public funding in the 6 biotech companies.

Eszter was SVP of Global Research at Intercell AG (now Valneva SAS) (1999-2010) and led a research team of up to 65 researchers and was responsible for discovery and research of ~20 infectious disease and vaccine projects, several of which were out-licensed to vaccine pharma and/or developed towards the clinic.

​Previously she worked in academic research (1990-1998) in the fields of molecular biology, cellular immunology, and cellular physiology at several institutions in the US (Dartmouth College and Medical School, Hanover, NH, and Roswell Park Cancer Institute, Buffalo, NY) and in Hungary (Medical University, Pécs, Hungary). She completed her medical degree in Hungary (Univ. Med. School of Pécs, 1990) and obtained her PhD in molecular biology. She has published over 90 original publications and book chapters and is the holder of more than 40 patents.

blu 2 bolle trasparenti.png
bottom of page